Cancel
About Ansu Kumar
Ansu Kumar is the Chief Scientific Officer leading the R&D modeling organization, focusing on creating in-vivo equivalent technology for disease physiology.
Known information
Ansu Kumar serves as the Chief Scientific Officer at a research organization, where he leads the development of in-vivo equivalent technology that models disease physiology with over a hundred thousand signaling and metabolic interactions. His work is pivotal in advancing the understanding of complex disease mechanisms. Additionally, Kumar has authored a blog post that discusses the impact of chronic stress on resistance to cancer therapies. He has also explored the role of stress-induced mutagenesis in the resistance to cancer treatments, contributing to the broader discourse on how psychological factors can influence the efficacy of medical therapies.
About Cellworks
Cellworks is a biotechnology company specializing in personalized therapy biosimulation for cancer treatment, utilizing its products like SingulaTM and VenturaTM to predict patient responses.
Report inaccurate information
